Earlier this month, in Novartis Pharms. Corp., Inc. v. Accord Healthcare, Inc., et al., No. 2021-1070, the Federal Circuit issued a helpful decision concerning the not-often-discussed written ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

On January 10 this year, the director of the USPTO issued new guidelines on enablement under 35 U.S.C §112. In recent years, the landscape of patent law in the United States has undergone a ...

“The listings of possibilities are so long, and so interwoven, that it is quite unclear how many compounds actually fall within the described genera and subgenera.” – CAFC In a precedential decision ...

Decision draws more scrutiny to the validity of broad claims and impacts the decision on when to file an application. In an en banc decision issued March 22, the Court of Appeals for the Federal ...

The court held that the “reference in the specification to a deposit in a public depository, which makes its contents accessible to the public when it is not otherwise available in written form, ...

May a court rely on post-priority-date evidence offered to show that a patent lacks written description support even though written description is judged based on the state of the art as of the ...